UroToday1d
ZZ-FIRST Trial Demonstrates High PSA Response with Combination Therapy - Joaquin Mateo
ZZ-FIRST Trial Demonstrates High PSA Response with Combination Therapy - Joaquin Mateo ...
UroToday3d
ESMO 2024: Scientific Congress Highlights: Genitourinary Tumors, Non-Prostate
(UroToday.com) The 2024 ESMO annual meeting included a highlights session, featuring a presentation by Dr. Ignacio Duran discussing highlights of the ESMO 2024 non-prostate cancer sessions. Dr. Duran ...
UroToday2d
Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer.
Partial cystectomy (PC) offers potential benefits for select patients with muscle-invasive bladder cancer (MIBC). However, the oncologic efficacy of PC may be compromised due to the underutilization ...
UroToday3d
One Simulated Skills Checkoff is Still Not Enough: Foley Catheterization Skill Performance Among Undergraduate Nursing Students
Retaining competent skill performance is difficult for nursing students. In this study participants had difficulty maintaining asepsis during a random skill assessment. Faculty should provide ...
UroToday3d
Ischemic gangrene of the penis due to Fournier's gangrene following traumatic transurethral catheterization: A case report.
Fournier's gangrene is a life-threatening fascial infection. We report a case of a 65-year-old diabetic man with a history of obstructive prostate growth who developed ischemic penile gangrene ...
UroToday3d
Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
Human tumors are intricate ecosystems composed of diverse genetic clones and malignant cell states that evolve in a complex tumor micro-environment. Single-cell RNA-sequencing (scRNA-seq) provides a ...
UroToday4d
ESMO 2024: INSPIRE: Phase 2 Trial of Nivolumab 3mg/kg and Ipilimumab 1mg/kg in Molecularly Selected Patients with mCRPC
(UroToday.com) The 2024 ESMO annual meeting included a session on prostate cancer, featuring a presentation by Dr. Niven Mehra discussing nivolumab 3mg/kg and ipilimumab 1mg/kg in molecularly selected ...
UroToday3d
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes
Background: There are limited data on the physical effects of androgen deprivation therapy (ADT) for prostate cancer (PC), and on the relationships of such measures of adiposity and strength to ...
UroToday3d
Development and first-in-human testing of FLUME urinary catheter with protected tip and relocated drainage holes.
Evaluation of a catheter design which protects its tip with the retaining balloon when inflated, and has eyeholes at the base of the balloon to improve drainage. Preclinical tests included assessment ...
UroToday3d
Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study.
To provide a baseline comparative assessment of the main epidemiological features of prostate cancer in European populations as background for the proposed EU screening initiatives. Population based ...
UroToday3d
Comparative simulated insertion between T-Control® and Foley-type catheter in nursing students with no prior training
Aims: To simulate the insertion of the new T-Control® urinary catheter with first-year nursing students without previous experience in bladder catheterization and assess the functionality and students ...
UroToday4d
ESMO 2024: Is There a Role for Radiation Therapy in Advanced RCC?
(UroToday.com) The 2024 European Society of Medical Oncology (ESMO) Annual Congress held in Barcelona, Spain was host to the session Updates in the management of advanced renal cell carcinoma. Dr.